{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:16:10Z","timestamp":1783545370934,"version":"3.55.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/md.0000000000011744","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T20:52:58Z","timestamp":1533243178000},"page":"e11744","source":"Crossref","is-referenced-by-count":27,"title":["The Prognostic Factors of Alcoholic Cardiomyopathy"],"prefix":"10.1097","volume":"97","author":[{"given":"Wei","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-101-20210226","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.mayocp.2013.11.005","article-title":"Alcohol and cardiovascular health: the dose makes the poison\u2026or the remedy","volume":"89","author":"O\u2019Keefe","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"R2-101-20210226","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"R3-101-20210226","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0002-9149(00)00706-2","article-title":"Alcohol abuse and dilated cardiomyopathy in men","volume":"85","author":"Gavazzi","year":"2000","journal-title":"Am J Cardiol"},{"key":"R4-101-20210226","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM198902163200701","article-title":"The effects of alcoholism on skeletal and cardiac muscle","volume":"320","author":"Urbano-Marquez","year":"1989","journal-title":"N Engl J Med"},{"key":"R5-101-20210226","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/euhj.1999.1761","article-title":"Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy","volume":"21","author":"Fauchier","year":"2000","journal-title":"Eur Heart J"},{"key":"R6-101-20210226","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.eurheartj.a014842","article-title":"Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy","volume":"17","author":"Prazak","year":"1996","journal-title":"Eur Heart J"},{"key":"R7-101-20210226","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-8703(98)70042-0","article-title":"Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study","volume":"135","author":"McKenna","year":"1998","journal-title":"Am Heart J"},{"key":"R8-101-20210226","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.121.5.1638","article-title":"Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology","volume":"121","author":"Piano","year":"2002","journal-title":"Chest"},{"key":"R9-101-20210226","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"R10-101-20210226","first-page":"711","article-title":"Mortality of dilated myocardiopathies as a function of continuation of alcohol drinking. Multivariate analysis concerning 236 patients","volume":"18","author":"Haissaguerre","year":"1989","journal-title":"Presse Med"},{"key":"R11-101-20210226","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jchf.2014.07.014","article-title":"Natural history and prognostic factors in alcoholic cardiomyopathy","volume":"3","author":"Guzzo-Merello","year":"2015","journal-title":"JACC Heart Fail"},{"key":"R12-101-20210226","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-74-5-681","article-title":"Alcoholic cardiomyopathy managed with prolonged bed rest","volume":"74","author":"McDonald","year":"1971","journal-title":"Ann Intern Med"},{"key":"R13-101-20210226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-80-3-293","article-title":"The natural course of alcoholic cardiomyopathy","volume":"80","author":"Demakis","year":"1974","journal-title":"Ann Intern Med"},{"key":"R14-101-20210226","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjcard.2010.04.021","article-title":"Relation of QRS duration in healthy persons to risk of future permanent pacemaker implantation","volume":"106","author":"Cheng","year":"2010","journal-title":"Am J Cardiol"},{"key":"R15-101-20210226","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjcard.2003.09.053","article-title":"Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction","volume":"93","author":"Sandhu","year":"2004","journal-title":"Am J Cardiol"},{"key":"R16-101-20210226","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0972-6292(16)30544-7","article-title":"Fragmented QRS: what was the meaning?","volume":"12","author":"Take","year":"2012","journal-title":"Indian Pacing Electrophysiol J"},{"key":"R17-101-20210226","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.amjcard.2005.08.046","article-title":"Comparison of mortality risk for electrocardiographic abnormalities in men and women with and without coronary heart disease (from the Cardiovascular Health Study)","volume":"97","author":"Rautaharju","year":"2006","journal-title":"Am J Cardiol"},{"key":"R18-101-20210226","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehs305","article-title":"Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction","volume":"34","author":"Lund","year":"2013","journal-title":"Eur Heart J"},{"key":"R19-101-20210226","first-page":"1099","article-title":"Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronwasation capability","volume":"70","author":"Lelakowski","year":"2012","journal-title":"Kardiol Pol"},{"key":"R20-101-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/174182670301000103","article-title":"Alcohol and cardiovascular disease-more than one paradox to consider. Alcohol and hypertension-does it matter? (no!)","volume":"10","author":"Lip","year":"2003","journal-title":"J Cardiovasc Risk"},{"key":"R21-101-20210226","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM197705262962103","article-title":"Alcohol consumption and blood pressure. Kawaser-Permanente multiphasic health examination data","volume":"296","author":"Klatsky","year":"1977","journal-title":"N Engl J Med"},{"key":"R22-101-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jacc.2006.04.109","article-title":"Influence of blood pressure on the effectiveness of a fixed-dose combination of wasosorbide dinitrate and hydralazine in the African-American Heart Failure Trial","volume":"49","author":"Anand was","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R23-101-20210226","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10741-012-9315-1","article-title":"Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure","volume":"18","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail Rev"},{"key":"R24-101-20210226","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2008.09.011","article-title":"Clinical outcomes accord- ing to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program","volume":"52","author":"Meredith","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R25-101-20210226","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ahj.2012.11.004","article-title":"Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial","volume":"165","author":"Ambrosy","year":"2013","journal-title":"Am Heart J"},{"key":"R26-101-20210226","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/13547501003632580","article-title":"New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis","volume":"15","author":"Baggwash","year":"2010","journal-title":"Biomarkers"},{"key":"R27-101-20210226","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/oxfordjournals.eurheartj.a060633","article-title":"Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring","volume":"15","author":"Scrutinio","year":"1994","journal-title":"Eur Heart J"},{"key":"R28-101-20210226","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/heart.89.6.605","article-title":"Predicting mortality in patients with heart failure: a pragmatic approach","volume":"89","author":"Bouvy","year":"2003","journal-title":"Heart"},{"key":"R29-101-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-0034-1376966","article-title":"Fasting blood glucose at admission and survival in patients with dilated cardiomyopathy: a single-center cohort study","volume":"122","author":"Li","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:48Z","timestamp":1620962388000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201808030-00101"}},"subtitle":["A single-center cohort study"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011744","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}